D'yakonova I N, Kamkina O V, Ishanova Yu S, Rakhmanova I V, Burmistrova D S
Department of Physiology, Medico-Biological Faculty, Moscow, Russia.
Department of Pharmacology, Moscow, Russia.
Bull Exp Biol Med. 2015 Aug;159(4):415-9. doi: 10.1007/s10517-015-2979-5. Epub 2015 Sep 18.
In chronic experiments on immature rabbits receiving therapeutic courses of vancomycin, gentamicin, and consecutive administration of vancomicin and gentamicin by the scheme used in neonatology, hearing function was evaluated by the methods of auditory evoked potentials (auditory brainstem response, ABR) and distortion product otoacoustic emission (DPOAE). Comparison with the control group revealed ototoxic effects of all studied antibiotics that manifested in increased sound tolerance and more rapid shortening of latencies in 30-100 dB range. Higher thresholds were found only after gentamicin administration. Vancomycin administration significantly reduced the responses at 4 kHz. Subsequent gentamicin course did not potentiate this effect.
在对接受万古霉素、庆大霉素治疗疗程以及按照新生儿科使用方案连续给予万古霉素和庆大霉素的未成熟兔进行的慢性实验中,通过听觉诱发电位(听觉脑干反应,ABR)和畸变产物耳声发射(DPOAE)方法评估听力功能。与对照组比较发现,所有研究的抗生素均有耳毒性作用,表现为声音耐受性增加以及在30 - 100分贝范围内潜伏期更快缩短。仅在给予庆大霉素后发现阈值升高。给予万古霉素显著降低了4千赫兹处的反应。随后的庆大霉素疗程并未增强此效应。